US$ 21.76
bpc-157 dosage for tendon repair Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157: Tendon Repair and More
Description
So this is the GHK-Cu Glow Pen, which I started taking back in August

This relatively short chain length contributes to its stability and ease of administration compared to larger protein structures

doi: 10.1038/sj.ijo.0803344

New growth factor therapies aimed at improving intestinal adaptation in short bowel syndrome

Additional observations potentiate that the peptide might promote fibroblast migration, a process relevant to cytoskeletal dynamics and tissue remodeling
